Oil Is the New Gold
Health Care: Health Services
Harvard Bioscience Inc. (HBIO: NASDAQ)
$5.03 -0.03 | -0.59%
06/19/13 - 02:23 PM ET
Company Cash Flow
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | 2.37M | 0.00 | 19.02M | 7.23M |
| Operating Gains/Losses | -24.00K | -19.00K | -444.00K | -2.59M |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | 229.00K | 159.00K | -965.00K | 4.34M |
| (Increase) Decrease in Inventories | 1.17M | -1.70M | -1.24M | -41.00K |
| (Increase) Decrease In Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| (Decrease) Increase In Payables | -905.00K | 69.00K | 56.00K | -1.02M |
| (Decrease) Increase In Other Current Liabilities | -194.00K | -1.88M | 852.00K | 1.94M |
| (Increase) Decrease In Other Working Capital | -48.00K | -496.00K | 58.00K | 0.00 |
| Other Non-Cash Items | 1.93M | 6.95M | 2.68M | 2.74M |
| Net Cash From Continuing Operations | 8.06M | 6.65M | 12.29M | 16.51M |
| Net Cash From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | 8.06M | 6.65M | 12.29M | 16.51M |
| Sale of Property, Plant & Equipment | 33.00K | 25.00K | 31.00K | 4.00K |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchases of Property, Plant & Equipment | -1.77M | -1.51M | -844.00K | -1.38M |
| Acquisitions | -2.88M | -5.46M | -7.12M | -20.76M |
| Purchases of Short-Term Investments | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Cash from Investing Activities | -62.00K | -252.00K | -418.00K | -164.00K |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | -4.68M | -7.20M | -8.35M | -22.30M |
| Issuance of Debt | 500.00K | 0.00 | 10.35M | 16.90M |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 2.29M | 567.00K | 282.00K | 271.00K |
| Repayment of Long-Term Debt | -3.85M | -1.71M | -5.66M | -4.98M |
| Repurchase of Capital Stock | 0.00 | 0.00 | -5.00M | -2.40M |
| Payment of Cash Dividends | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Charges, Net | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Cash From Financing Activities | -1.06M | -1.14M | -31.00K | 9.78M |
| Effect of Exchange Rate Changes | 442.00K | -97.00K | -800.00K | -1.10M |
| Net Change in Cash & Cash Equivalents | 2.76M | -1.79M | 3.12M | 2.89M |
Portfolios with HBIO
- Portfolio NameUser Type
- UserJoePa66
- Contributor5 Stocks Under-$10 Setting ...
- ContributorTheStreet Ratings Top-Rated...
- UserMike's Safe Play Portfolio
- UserRocket Stocks For The Week ...
- UserRocket Stocks For The Week ...
- UserRocket Stocks For The Week ...
- Userjim c's Portfolio 1
- UserRocket Stocks For The Week ...
- UserTom's Stuff
Latest HBIO Headlines from TheStreet
- Harvard Bioscience Inc. Stock Downgraded (HBIO) 06.04.13 | 10:06 am
- Harvard Bioscience Announces Retirement Of CEO And Appointment Of Interim CEO 05.15.13 | 07:05 am
- HBIO Reports First Quarter 2013 Results 05.02.13 | 07:05 am
- HBIO Affirms Plan To Spin-Off Harvard Apparatus Regenerative Technology, Inc. And Announces Its Intended Path Forward 05.01.13 | 05:05 pm
- Webcast Now Available Of Press Conference Discussing Landmark Surgery Involving Harvard Bioscience's Synthetic Trachea Scaffold And "InBreath" Bioreactor 04.30.13 | 07:04 pm
- Photo Release -- Harvard Apparatus Regenerative Technology's "InBreath" Scaffold And Bioreactor Used In First U.S. Transplant Of A Regenerated Trachea 04.30.13 | 11:04 am
- Harvard Bioscience To Participate In Press Conference Today To Discuss Landmark Surgery 04.30.13 | 07:04 am
- Harvard Bioscience, Inc. Schedules First Quarter 2013 Conference Call For May 2, 2013 04.26.13 | 02:04 pm
- The Five Dumbest Things on Wall Street: April 12
04.12.13 | 05:04 am - HBIO Announces Postponement Of The IPO For Harvard Apparatus Regenerative Technology, Inc. 04.09.13 | 05:04 pm
Press Releases for HBIO
- SeeThruEquity Launches First Free Institutional Equity Research Platform - Business Wire 06.23.11 | 10:06 am
- Cellectis Grants Harvard Bioscience A License To CytoPulse Electroporation Instruments - PR Newswire 12.02.10 | 02:12 am
Partner Headlines for HBIO
- Investment Potential In Electroporation Companies - Seeking Alpha 07.17.12 | 09:07 am
- 16 Stocks Under $5 Being Bought Up By Insiders And The Smart Money - Seeking Alpha 09.16.11 | 05:09 pm
- 5 Likely Additions to the Russell 2000 - Seeking Alpha 05.04.11 | 08:05 am
